ShiraTronics

AMA CPT Editorial Panel Acceptance of Five Category III Codes Establishes Coding Infrastructure for Bilateral Supraorbital-Occipital Neurostimulator Services Ahead of Anticipated Regulatory Submission

Brad Vale was head of Johnson & Johnson Development Corporation from 2011 to 2015. The organization is Johnson & Johnson’s venture investing arm, with offices in Silicon Valley, Boston, Shanghai, London, and Tel Aviv.

Casey Tansey joined USVP as a general partner in 2005 and has more than 30 years of entrepreneurial, early-stage medical device, and operating experience.

Joyce Erony has more than 30 years of experience in investing, business development, and investment banking. Before founding Amzak Health in 2015, she was a managing director at Signet Healthcare Partners, a growth capital healthcare fund in New York.

Lynn Elliott co-founded ShiraTronics and has three decades of active implantable device experience in innovation, R&D, manufacturing, clinical trials, and regulatory approvals.

ShiraTronics is a privately held medical device company located in St Paul, Minnesota. Its team has developed a device intended to address chronic migraine disease.

The company’s mission is to transform the lives of people with chronic migraine. The page says neuromodulation may help when medications do not reduce the frequency or severity of migraine attacks.

ShiraTronics’ privacy policy describes the data the company may collect from visitors to its website and its practices for collecting, using, and disclosing that data.